![](https://investorshub.advfn.com/uicon/695588.png?cb=1547076593)
Monday, February 11, 2019 3:52:04 PM
Cochrane take no 'commercial or conflicted funding'. Any dilution of their fiercely independent stance would be a great shame.
I think the recent Gates Foundation funding is a big negative for them; it is essentially conflicted funding because Gates are all about using vaccines to solve third world health problems. Any critical analysis of a vaccine they are behind is going to be an issue. The trigger for Gotzsche’s defenestration (sorry, just like the way it sounds) was the Gardasil review.
Dr Malcolm Kendrick, who you are no doubt familiar with, went this far in describing the potential impact on Cochrane:
one wonders if the lamps truly are turning out across the world. Perhaps never to be turned on again.
A definite difference in tone from his typical cynical, joking, acute observations.
http://drmalcolmkendrick.org/2018/09/19/peter-gotzsche-a-scandal/amp/
What I do know is that if you read his book: 'Deadly Medicines and Organised Crime. How big pharma has corrupted healthcare.' you will never view things quite the same again. I have a copy.
It’s been on my list to pick up — this series of posts has motivated me to take the plunge. I’m very interested in seeing the level of evidence he brings in making the case that BP is essentially organized crime. It’s a provocative question: how close does that model match?
As Johnnie Cochran might say, “If the glove fits tight, you must indict.”
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM